S 3385
116th Congress
Senate
Health
Drug safety, medical device, and laboratory regulation
Health information and medical records
Product development and innovation
BENEFIT Act of 2020
Introduced: March 4, 2020
Introduced by:
Wicker, Roger F.
Republican
· Mississippi
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 4, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 4, 2020
Introduced in Senate
Plain-English summary
Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2020 or the BENEFIT Act of 2020
This bill requires the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs.
After a new drug application has been approved, the FDA's public statement about how it used patient experience data shall include a description of how such data was considered in the risk-benefit assessment framework.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committees of jurisdiction
1
Cosponsors
1